ch 8 exam review

Chapter 8: Psychotic Disorders and Antipsychotics

DSM-5: Psychotic Disorders

  • Psychotic Disorders Overview

    • Characterized by significant impairment in thought processes, perception, and emotional regulation.

    • Major Types:

      • Schizotypal Personality Disorder

        • Discomfort in close relationships.

        • Cognitive or perceptual distortions, including magical thinking (e.g. telepathy).

        • Ideas of reference and odd thinking/speaking.

      • Delusional Disorder

        • More than one month of delusions.

        • Key characteristics: falsity of beliefs, resistant to change.

        • Can feature bizarre delusions such as thought insertion or broadcasting.

      • Brief Psychotic Disorder

        • Episode lasts less than one month with at least one symptom of schizophrenia.

        • Resembles an emotional breakdown.

      • Schizophreniform Disorder

        • Symptoms meet schizophrenia criteria but last less than six months.

      • Schizophrenia

        • Required criteria: Two or more symptoms present for over six months, including delusions, hallucinations, and disorganized behavior.

      • Schizoaffective Disorder

        • Meets criteria for both schizophrenia and mood disorders (either MDD or BPD).

Delusional Disorder Details

  • Delusions

    • Definition: a false belief that remains unchanged despite contradictory evidence.

    • Types of delusions:

      • Bizarre delusions (implausible).

      • Examples:

        • Thought insertion: Others are inserting thoughts.

        • Thought broadcasting: Belief that thoughts are accessible to others.

        • External control: Belief that thoughts are controlled externally.

  • Cultural Considerations:

    • Culturally held beliefs, even if bizarre, do not qualify as a disorder if generally accepted within that culture (e.g., Koro, Wendigo).

  • Diagnosis Criteria

    • No requirements of functional impairments other than delusions.

    • Delusions can be tactile/olfactory if related to the delusion.

    • Must specify type: erotomanic, grandiose, jealous, persecutory, somatic, mixed, unspecified.

Schizophrenia Overview

  • Diagnostic Criteria

    • Two or more symptoms prolonged for at least six months, including:

      • Delusions.

      • Hallucinations.

      • Disorganized speech.

      • Grossly abnormal behavior (catatonia).

      • Negative symptoms.

  • Symptom Types:

    • Positive Symptoms: Hyperactivity of the mesolimbic system.

      • Includes delusions, hallucinations (predominantly auditory), and disorganized speech.

    • Negative Symptoms: Hypoactivity in the mesocortical system.

      • Affective flattening, alogia, avolition, apathy, anhedonia, attentional impairment.

  • Symptom Impact on Functioning:

    • Negative symptoms correlate more with real-world functioning than positive symptoms.

Hallucinations in Schizophrenia

  • Prevalence: 70-83% of individuals experience hallucinations, predominantly auditory.

  • Types of Hallucinations:

    • Visual (30-57%).

    • Tactile, olfactory, gustatory (14-27%).

  • Symptom Presentation:

    • Paranoid, disorganized, or depressive presentations with varying symptoms and attitudes.

Differentiation from Other Disorders

  • Psychotic symptoms can occur in various psychiatric disorders including bipolar disorder, major depression, schizoaffective disorder, and dementias like Alzheimer's and Lewy body dementia.

Prevalence and Heritability

  • Delusional Disorder:

    • Rarity: 0.05-0.1%.

    • Heritability: 31-39%.

  • Schizophrenia:

    • Prevalence: Approximately 0.5%, equal gender distribution.

    • Heritability significant: 80% (high concordance in MZ twins compared to DZ twins).

Neurobiology of Schizophrenia

  • Focus on Dopamine Pathways:

    • Mesolimbic Pathway: Involved in positive symptoms; D2 receptor blockade can reduce symptoms but may reduce motivation.

    • Mesocortical Pathway: Involved in negative symptoms; dysfunction can cause cognitive issues.

    • Nigrostriatal and Tuberoinfundibular Pathways: Related to motor side effects and prolactin secretion, respectively.

    • Serotonin's Role:

      • Influences dopamine release; modulation may help with treatment efficacy.

Antipsychotics Overview

  • Types of Antipsychotics:

    • First-Generation (Typical): Primarily D2 blockers.

    • Second-Generation (Atypical): Block both DA and 5-HT2A, can be more effective for negative symptoms.

  • Key Antipsychotics Introduced:

    • Chlorpromazine (1950), Haloperidol (1958), Clozapine (1990), and others.

Side Effects of Antipsychotics

  • Elderly Patients with Dementia:

    • Increased risk of death, particularly from cardiac and cerebrovascular incidents.

    • Box warning for all antipsychotics when used in geriatric patients.

Considerations in Choosing Antipsychotics

  • Evaluation of patient history and existing conditions to ensure correct diagnosis and treatment options.

  • Addressing possible non-compliance and understanding the therapeutic range and the time required for medication to take effect.

robot